Re: A Twenty-year Experience With Endoscopic Therapy for Symptomatic Primary Sclerosing Cholangitis.

[Guest guest]

I WOULD LIKE TO KNOW WHAT THE DOCTORS STUDYING THE EFFECTS OF ENDOSCOPIC THERAPY CONSIDERED AS COMPLICATIONS. DID THEY INCLUDE THE PANCREATITIS AND OTHER INFECTIONS OR ONLY DAMAGE DONE TO THE DUCTS AND OTHER TISSUE? i ALWAYS FELT THE ERCPs I HAD DONE WERE OF VALUE, BUT I HOPE THEY RECOGNIZED THE PROBLEMS WITH INFECTION MANY OF US HAVE HAD.

A Twenty-year Experience With Endoscopic Therapy for Symptomatic Primary Sclerosing Cholangitis.

Recent Activity

11

New Members

Visit Your Group

Yahoo! Health

Heartburn or Worse

What symptoms

are most serious?

Meditation and

Lovingkindness

A Yahoo! Group

to share and learn.

Yahoo! Groups

w/ McEnroe

Join the All-Bran

Day 10 Club.

http://www.jcge.com/pt/re/jclngastro/abstract.00004836-200810000-00012.htm;jsessionid=LXQbNkL4gPFJm1g4298bJQpxLsfzMTGFhRM0cLB2w8X16xTvY18J!1455807198!181195628!8091!-1

A Twenty-year Experience With Endoscopic Therapy for Symptomatic Primary Sclerosing Cholangitis.

LIVER, PANCREAS AND BILIARY TRACT

Journal of Clinical Gastroenterology. 42(9):1032-1039, October 2008.

Gluck, MD; Cantone, Nico R. BS; Brandabur, J. MD; , J. MD; Bredfeldt, E. MD; Kozarek, A. MD

Abstract:

Goals: The current study presents 1 tertiary endoscopy center's 20-year experience using endoscopic therapy to treat patients with symptomatic primary sclerosing cholangitis (PSC).

Background: Endoscopic therapy for patients with PSC and dominant strictures has been used for more than 20 years, but there is concern that instrumenting a sclerotic biliary tree induces risks that outweigh anticipated benefits.

Study: In this retrospective chart review, 117 patients with PSC were identified using ICD-9 codes. Patients had a mean age of 47 years (range: 15 to 86 y). Mean duration of follow-up was 8 years (range: 2 to 20 y). Of the 117 identified patients, 106 underwent endoscopic retrograde cholangiopancreatography on one or more occasions (for a total of 317 endoscopic retrograde cholangiopancreatographies), and a subset of 84 patients received endoscopic therapy for treatment of dominant strictures and/or deteriorating clinical status. Actual survival for endoscopically treated patients was compared with predicted survival using the Mayo Clinic natural history model for PSC.

Results: Our chart review revealed 23 recognized complications among the 317 procedures performed (7.3%), and no procedure-related deaths. Observed patient survival at years 3 and 4 was significantly higher than that predicted by the Mayo Clinic natural history model for PSC (P=0.021).

Conclusions: Patients with PSC who have a deteriorating clinical course benefited from endoscopic therapy to provide drainage of bile ducts, removal of stones, and/or temporary relief from obstructions, with acceptable procedure-related complications and higher than expected 3-year and 4-year survival.

© 2008 Lippincott & Wilkins, Inc.

Find phone numbers fast with the New AOL Yellow Pages!